Jacobs Levy Equity Management Inc. Cuts Stake in Seer, Inc. (NASDAQ:SEER)

Jacobs Levy Equity Management Inc. cut its holdings in shares of Seer, Inc. (NASDAQ:SEER) by 4.2% during the third quarter, Holdings Channel.com reports. The institutional investor owned 445,618 shares of the company’s stock after selling 19,375 shares during the period. Jacobs Levy Equity Management Inc.’s holdings in Seer were worth $878,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. Acadian Asset Management LLC raised its stake in shares of Seer by 35.5% in the second quarter. Acadian Asset Management LLC now owns 1,802,106 shares of the company’s stock valued at $3,024,000 after acquiring an additional 472,283 shares in the last quarter. Point72 Asia Singapore Pte. Ltd. purchased a new stake in Seer during the 2nd quarter worth about $148,000. GSA Capital Partners LLP raised its position in Seer by 194.9% in the 3rd quarter. GSA Capital Partners LLP now owns 127,868 shares of the company’s stock valued at $252,000 after purchasing an additional 84,515 shares in the last quarter. Cubist Systematic Strategies LLC purchased a new position in shares of Seer in the 2nd quarter valued at about $133,000. Finally, Vanguard Group Inc. increased its stake in shares of Seer by 1.0% during the first quarter. Vanguard Group Inc. now owns 2,636,577 shares of the company’s stock worth $5,009,000 after buying an additional 25,944 shares during the period. Hedge funds and other institutional investors own 75.20% of the company’s stock.

Analyst Upgrades and Downgrades

Separately, Morgan Stanley reduced their price objective on shares of Seer from $7.00 to $3.00 and set an “equal weight” rating on the stock in a report on Tuesday, August 13th.

Seer Trading Up 1.2 %

SEER stock opened at $2.48 on Monday. The company’s 50 day moving average is $2.14 and its two-hundred day moving average is $1.89. The stock has a market cap of $146.25 million, a P/E ratio of -1.91 and a beta of 1.58. Seer, Inc. has a twelve month low of $1.51 and a twelve month high of $2.63.

Seer Company Profile

Seer, Inc, a life sciences company, engages in developing and commercializing products to decode the biology of the proteome. It develops Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only.